NCT06136936 - A Study to Evaluate the Overall Effects of Treatment With Abbreviated CT-156 in People With Schizophrenia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 20, 2023

Primary Completion Date

January 18, 2024

Study Completion Date

February 22, 2024

Conditions

Schizophrenia

Interventions

DEVICE

CT-156-C-001

CT-156 is a digital therapeutic (DTx) under development to treat patients 18 years of age and older with a diagnosis of schizophrenia under standard of care therapy who are on antipsychotic medication and not currently experiencing acute hallucinations or delusions.

Trial Locations (1)

10013

Click Therapeutics, New York